Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research, and pharmaceutical development.
They produce primary and secondary antibodies for:
- Apoptosis,
- Cellular Senescence,
- Bacterial Chemotaxis,
- Regulation of the Actin Cytoskeleton
- Autophagy,
- Endocytosis,
- Peroxisome,
- Phagosome,
- Biofilm Formation,
- Quorum Sensing,
- and many other signaling pathways.
